Annual accounts receivable:
$452.50M-$36.50M(-7.46%)Summary
- As of today (May 29, 2025), BIO annual accounts receivable is $452.50 million, with the most recent change of -$36.50 million (-7.46%) on December 31, 2024.
- During the last 3 years, BIO annual accounts receivable has risen by +$28.96 million (+6.84%).
- BIO annual accounts receivable is now -8.52% below its all-time high of $494.64 million, reached on December 31, 2022.
Performance
BIO Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$424.70M-$27.80M(-6.14%)Summary
- As of today (May 29, 2025), BIO quarterly accounts receivable is $424.70 million, with the most recent change of -$27.80 million (-6.14%) on March 31, 2025.
- Over the past year, BIO quarterly accounts receivable has dropped by -$20.11 million (-4.52%).
- BIO quarterly accounts receivable is now -14.77% below its all-time high of $498.27 million, reached on March 31, 2023.
Performance
BIO Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BIO Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.5% | -4.5% |
| 3 y3 years | +6.8% | -8.5% |
| 5 y5 years | +15.2% | +11.6% |
BIO Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.5% | +6.8% | -14.8% | at low |
| 5 y | 5-year | -8.5% | +15.2% | -14.8% | +17.7% |
| alltime | all time | -8.5% | +148.3% | -14.8% | +133.0% |
BIO Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $424.70M(-6.1%) |
| Dec 2024 | $452.50M(-7.5%) | $452.50M(-2.0%) |
| Sep 2024 | - | $461.94M(+3.7%) |
| Jun 2024 | - | $445.51M(+0.2%) |
| Mar 2024 | - | $444.81M(-9.0%) |
| Dec 2023 | $489.00M(-1.1%) | $489.00M(+6.9%) |
| Sep 2023 | - | $457.40M(-7.0%) |
| Jun 2023 | - | $491.57M(-1.3%) |
| Mar 2023 | - | $498.27M(+0.7%) |
| Dec 2022 | $494.64M(+16.8%) | $494.64M(+14.4%) |
| Sep 2022 | - | $432.30M(-4.0%) |
| Jun 2022 | - | $450.32M(-3.0%) |
| Mar 2022 | - | $464.11M(+9.6%) |
| Dec 2021 | $423.54M(+1.0%) | $423.54M(+1.4%) |
| Sep 2021 | - | $417.71M(+4.6%) |
| Jun 2021 | - | $399.31M(-2.2%) |
| Mar 2021 | - | $408.14M(-2.7%) |
| Dec 2020 | $419.42M(+6.8%) | $419.42M(+4.3%) |
| Sep 2020 | - | $402.24M(+11.5%) |
| Jun 2020 | - | $360.85M(-5.2%) |
| Mar 2020 | - | $380.48M(-3.1%) |
| Dec 2019 | $392.67M(+0.1%) | $392.67M(+10.3%) |
| Sep 2019 | - | $356.02M(-5.8%) |
| Jun 2019 | - | $377.90M(-3.5%) |
| Mar 2019 | - | $391.70M(-0.2%) |
| Dec 2018 | $392.44M(-15.6%) | $392.44M(+2.9%) |
| Sep 2018 | - | $381.53M(-5.6%) |
| Jun 2018 | - | $404.09M(-6.1%) |
| Mar 2018 | - | $430.36M(-7.4%) |
| Dec 2017 | $464.85M(+24.8%) | $464.85M(+10.8%) |
| Sep 2017 | - | $419.71M(+6.8%) |
| Jun 2017 | - | $392.84M(+5.2%) |
| Mar 2017 | - | $373.44M(+0.3%) |
| Dec 2016 | $372.35M(-4.9%) | $372.35M(+1.3%) |
| Sep 2016 | - | $367.66M(+0.4%) |
| Jun 2016 | - | $366.28M(-3.9%) |
| Mar 2016 | - | $381.10M(-2.7%) |
| Dec 2015 | $391.49M(+3.7%) | $391.49M(+14.6%) |
| Sep 2015 | - | $341.55M(-3.6%) |
| Jun 2015 | - | $354.16M(+3.5%) |
| Mar 2015 | - | $342.22M(-9.4%) |
| Dec 2014 | $377.64M(-10.7%) | $377.64M(+6.6%) |
| Sep 2014 | - | $354.40M(-6.5%) |
| Jun 2014 | - | $378.89M(-1.3%) |
| Mar 2014 | - | $383.93M(-9.2%) |
| Dec 2013 | $422.66M(+6.0%) | $422.66M(+10.2%) |
| Sep 2013 | - | $383.47M(-3.2%) |
| Jun 2013 | - | $395.97M(+4.9%) |
| Mar 2013 | - | $377.55M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $398.74M(+0.0%) | $398.74M(+6.1%) |
| Sep 2012 | - | $375.80M(+0.5%) |
| Jun 2012 | - | $373.82M(-3.6%) |
| Mar 2012 | - | $387.62M(-2.8%) |
| Dec 2011 | $398.67M(+2.8%) | $398.67M(+6.3%) |
| Sep 2011 | - | $375.03M(-5.0%) |
| Jun 2011 | - | $394.91M(+1.6%) |
| Mar 2011 | - | $388.55M(+0.1%) |
| Dec 2010 | $388.00M(+12.2%) | $388.00M(+5.3%) |
| Sep 2010 | - | $368.60M(+9.9%) |
| Jun 2010 | - | $335.35M(-2.8%) |
| Mar 2010 | - | $344.99M(-0.2%) |
| Dec 2009 | $345.73M(+1.8%) | $345.73M(-1.4%) |
| Sep 2009 | - | $350.76M(+4.4%) |
| Jun 2009 | - | $335.83M(+2.9%) |
| Mar 2009 | - | $326.31M(-3.9%) |
| Dec 2008 | $339.65M(-5.1%) | $339.65M(-2.5%) |
| Sep 2008 | - | $348.25M(-7.6%) |
| Jun 2008 | - | $376.99M(+2.9%) |
| Mar 2008 | - | $366.51M(+2.4%) |
| Dec 2007 | $358.08M(+22.2%) | $358.08M(+18.1%) |
| Sep 2007 | - | $303.20M(-0.0%) |
| Jun 2007 | - | $303.27M(+4.5%) |
| Mar 2007 | - | $290.12M(-1.0%) |
| Dec 2006 | $292.97M(+18.5%) | $292.97M(+7.2%) |
| Sep 2006 | - | $273.37M(+0.1%) |
| Jun 2006 | - | $273.01M(+5.3%) |
| Mar 2006 | - | $259.23M(+4.9%) |
| Dec 2005 | $247.19M(-5.4%) | $247.19M(+1.1%) |
| Sep 2005 | - | $244.47M(+0.4%) |
| Jun 2005 | - | $243.39M(-3.0%) |
| Mar 2005 | - | $250.97M(-3.9%) |
| Dec 2004 | $261.24M(+11.6%) | $261.24M(+14.5%) |
| Sep 2004 | - | $228.19M(-2.5%) |
| Jun 2004 | - | $234.00M(+2.2%) |
| Mar 2004 | - | $228.93M(-2.2%) |
| Dec 2003 | $234.09M(+10.3%) | $234.09M(+7.5%) |
| Sep 2003 | - | $217.67M(+2.7%) |
| Jun 2003 | - | $211.92M(-1.0%) |
| Mar 2003 | - | $213.96M(+0.8%) |
| Dec 2002 | $212.28M(+9.2%) | $212.28M(+5.5%) |
| Sep 2002 | - | $201.26M(+0.6%) |
| Jun 2002 | - | $199.97M(+2.0%) |
| Mar 2002 | - | $196.00M(+0.8%) |
| Dec 2001 | $194.40M(+6.7%) | $194.40M(+4.3%) |
| Sep 2001 | - | $186.39M(-0.2%) |
| Jun 2001 | - | $186.71M(-2.7%) |
| Mar 2001 | - | $191.79M(+5.2%) |
| Dec 2000 | $182.24M | $182.24M |
FAQ
- What is Bio-Rad Laboratories annual accounts receivable?
- What is the all time high annual accounts receivable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual accounts receivable year-on-year change?
- What is Bio-Rad Laboratories quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly accounts receivable year-on-year change?
What is Bio-Rad Laboratories annual accounts receivable?
The current annual accounts receivable of BIO is $452.50M
What is the all time high annual accounts receivable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual accounts receivable is $494.64M
What is Bio-Rad Laboratories annual accounts receivable year-on-year change?
Over the past year, BIO annual accounts receivable has changed by -$36.50M (-7.46%)
What is Bio-Rad Laboratories quarterly accounts receivable?
The current quarterly accounts receivable of BIO is $424.70M
What is the all time high quarterly accounts receivable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly accounts receivable is $498.27M
What is Bio-Rad Laboratories quarterly accounts receivable year-on-year change?
Over the past year, BIO quarterly accounts receivable has changed by -$20.11M (-4.52%)